Methods for isolating a target analyte from a heterogenous sample
The invention generally relates to methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.
1. A method for isolating at least one pathogen from a heterogeneous sample, the method comprising:
obtaining a heterogeneous sample comprising at least one pathogen;
incubating the sample with a composition comprising a plurality of sets of magnetic particles specific to one or more pathogens, wherein members of a first set of magnetic particles are conjugated to a first class of capture moiety, and members of a second set of magnetic particles are conjugated to a second class of capture moiety;
separating particle bound pathogen from other components in the sample,
wherein the first and second classes of capture moiety are different.
2. The method of claim 1 , wherein each set of magnetic particles is present at a concentration designed for detection of a specific pathogen in said sample.
3. The method of claim 2 , wherein the first and second set of magnetic particles are provided at different concentrations.
4. The method of claim 1 , wherein the pathogen is selected from the group consisting of fungi, bacteria and a combination thereof.
5. The method of claim 4 , wherein the fungi comprises two or more species of fungi selected from the group consisting of the Candida genus, Aspergillus genus, and Cryptococcus genus.
6. The method of claim 4 , wherein the bacteria comprise one or species of bacteria selected from the group consisting of Staphylococcus genus, Enterobacteriaceae genus, Acinetobacter genus, Strenotrophomonas genus, Pseudomonas genus, Neisseria genus, Clostridium genus, and Enterococcus genus.
7. The method of claim 1 , further comprising lysing the separated pathogen to release nucleic acid.
8. The method of claim 7 , further comprising conducting an assay on the nucleic acid to identify the pathogen.
9. The method of claim 8 , wherein the assay is selected from the group consisting of a sequencing reaction and a polymerase chain reaction.
10. The method of claim 8 , wherein the assay is a multiplex assay.